Home » Analyst Articles – US

Image for Barclays Trims Smartsheet (NYSE:SMAR) Target Price to $40.00

Barclays Trims Smartsheet (NYSE:SMAR) Target Price to $40.00

Smartsheet (NYSE:SMAR – Get Free Report) had its price objective cut by analysts at Barclays from $50.00 to $40.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “equal weight”... More of this article »
Image for Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Raised to $375.00

Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Raised to $375.00

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) had its target price increased by investment analysts at Oppenheimer from $320.00 to $375.00 in a research report issued on Friday, Benzinga reports. The firm presently... More of this article »
Image for Loop Capital Increases Ulta Beauty (NASDAQ:ULTA) Price Target to $540.00

Loop Capital Increases Ulta Beauty (NASDAQ:ULTA) Price Target to $540.00

Ulta Beauty (NASDAQ:ULTA – Get Free Report) had its target price hoisted by investment analysts at Loop Capital from $530.00 to $540.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “hold”... More of this article »
Image for Canaccord Genuity Group Increases Century Therapeutics (NASDAQ:IPSC) Price Target to $24.00

Canaccord Genuity Group Increases Century Therapeutics (NASDAQ:IPSC) Price Target to $24.00

Century Therapeutics (NASDAQ:IPSC – Get Free Report) had its target price hoisted by investment analysts at Canaccord Genuity Group from $22.00 to $24.00 in a report issued on Friday, Benzinga reports. The brokerage currently... More of this article »
Image for Iron Mountain (NYSE:IRM) PT Raised to $90.00 at Wells Fargo & Company

Iron Mountain (NYSE:IRM) PT Raised to $90.00 at Wells Fargo & Company

Iron Mountain (NYSE:IRM – Get Free Report) had its price objective increased by investment analysts at Wells Fargo & Company from $80.00 to $90.00 in a report released on Friday, Benzinga reports. The brokerage currently... More of this article »
Image for Truist Financial Boosts DICK’S Sporting Goods (NYSE:DKS) Price Target to $243.00

Truist Financial Boosts DICK’S Sporting Goods (NYSE:DKS) Price Target to $243.00

DICK’S Sporting Goods (NYSE:DKS – Get Free Report) had its target price boosted by stock analysts at Truist Financial from $201.00 to $243.00 in a report issued on Friday, Benzinga reports. The firm presently has a “buy”... More of this article »
Image for Viking Therapeutics’ (VKTX) “Buy” Rating Reiterated at Maxim Group

Viking Therapeutics’ (VKTX) “Buy” Rating Reiterated at Maxim Group

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Maxim Group in a research note issued on Friday, Benzinga reports. They presently have a $120.00... More of this article »
Image for UiPath (NYSE:PATH) Price Target Raised to $28.00

UiPath (NYSE:PATH) Price Target Raised to $28.00

UiPath (NYSE:PATH – Get Free Report) had its price objective increased by equities researchers at TD Cowen from $25.00 to $28.00 in a report released on Thursday, Benzinga reports. The firm presently has an “outperform”... More of this article »
Image for SentinelOne (NYSE:S) PT Raised to $24.00

SentinelOne (NYSE:S) PT Raised to $24.00

SentinelOne (NYSE:S – Get Free Report) had its price objective upped by DA Davidson from $22.00 to $24.00 in a report issued on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock.... More of this article »
Image for First Wave BioPharma (NASDAQ:FWBI) Price Target Lowered to $36.00 at Roth Mkm

First Wave BioPharma (NASDAQ:FWBI) Price Target Lowered to $36.00 at Roth Mkm

First Wave BioPharma (NASDAQ:FWBI – Get Free Report) had its price target reduced by research analysts at Roth Mkm from $40.00 to $36.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently... More of this article »
Image for I-Mab (NASDAQ:IMAB) PT Lowered to $6.00

I-Mab (NASDAQ:IMAB) PT Lowered to $6.00

I-Mab (NASDAQ:IMAB – Get Free Report) had its price target lowered by investment analysts at Needham & Company LLC from $8.00 to $6.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has a... More of this article »
Image for HC Wainwright Reiterates Buy Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

HC Wainwright Reiterates Buy Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They presently have a $60.00... More of this article »
Image for Intuitive Machines (NASDAQ:LUNR) Rating Reiterated by Benchmark

Intuitive Machines (NASDAQ:LUNR) Rating Reiterated by Benchmark

Intuitive Machines (NASDAQ:LUNR – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Benchmark in a research report issued to clients and investors on Friday, Benzinga reports.... More of this article »
Image for Robinhood Markets (NASDAQ:HOOD) Price Target Increased to $20.00 by Analysts at Mizuho

Robinhood Markets (NASDAQ:HOOD) Price Target Increased to $20.00 by Analysts at Mizuho

Robinhood Markets (NASDAQ:HOOD – Get Free Report) had its price target upped by equities research analysts at Mizuho from $17.00 to $20.00 in a research report issued to clients and investors on Friday, Benzinga reports. The... More of this article »
Image for Smartsheet (NYSE:SMAR) PT Lowered to $36.00

Smartsheet (NYSE:SMAR) PT Lowered to $36.00

Smartsheet (NYSE:SMAR – Get Free Report) had its price target decreased by analysts at Royal Bank of Canada from $48.00 to $36.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “sector... More of this article »
Image for Robert W. Baird Cuts PagerDuty (NYSE:PD) Price Target to $22.00

Robert W. Baird Cuts PagerDuty (NYSE:PD) Price Target to $22.00

PagerDuty (NYSE:PD – Get Free Report) had its price target decreased by analysts at Robert W. Baird from $25.00 to $22.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has a “neutral”... More of this article »
Image for Co-Diagnostics (NASDAQ:CODX) Price Target Lowered to $2.50 at HC Wainwright

Co-Diagnostics (NASDAQ:CODX) Price Target Lowered to $2.50 at HC Wainwright

Co-Diagnostics (NASDAQ:CODX – Get Free Report) had its price target decreased by research analysts at HC Wainwright from $3.00 to $2.50 in a report released on Friday, Benzinga reports. The brokerage currently has a “neutral”... More of this article »
Image for Needham & Company LLC Raises Cardlytics (NASDAQ:CDLX) Price Target to $15.00

Needham & Company LLC Raises Cardlytics (NASDAQ:CDLX) Price Target to $15.00

Cardlytics (NASDAQ:CDLX – Get Free Report) had its target price hoisted by stock analysts at Needham & Company LLC from $12.00 to $15.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has... More of this article »
Image for Phillips 66 (NYSE:PSX) Price Target Increased to $180.00 by Analysts at Bank of America

Phillips 66 (NYSE:PSX) Price Target Increased to $180.00 by Analysts at Bank of America

Phillips 66 (NYSE:PSX – Get Free Report) had its price objective lifted by Bank of America from $150.00 to $180.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “neutral” rating... More of this article »
Image for Needham & Company LLC Reaffirms “Buy” Rating for Blink Charging (NASDAQ:BLNK)

Needham & Company LLC Reaffirms “Buy” Rating for Blink Charging (NASDAQ:BLNK)

Blink Charging (NASDAQ:BLNK – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Needham & Company LLC in a research note issued to investors on Friday, Benzinga reports. They... More of this article »
Image for Guess? (NYSE:GES) Given Market Perform Rating at Telsey Advisory Group

Guess? (NYSE:GES) Given Market Perform Rating at Telsey Advisory Group

Guess? (NYSE:GES – Get Free Report)‘s stock had its “market perform” rating reissued by Telsey Advisory Group in a research report issued on Friday, Benzinga reports. They presently have a $23.00 price objective... More of this article »
Image for Century Therapeutics (NASDAQ:IPSC) Rating Reiterated by HC Wainwright

Century Therapeutics (NASDAQ:IPSC) Rating Reiterated by HC Wainwright

Century Therapeutics (NASDAQ:IPSC – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research note issued on Friday, Benzinga reports. They currently have a... More of this article »
Image for HC Wainwright Reaffirms “Buy” Rating for Kopin (NASDAQ:KOPN)

HC Wainwright Reaffirms “Buy” Rating for Kopin (NASDAQ:KOPN)

Kopin (NASDAQ:KOPN – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They currently have a $3.00... More of this article »
Image for Logitech International’s (LOGI) “Neutral” Rating Reiterated at Wedbush

Logitech International’s (LOGI) “Neutral” Rating Reiterated at Wedbush

Logitech International (NASDAQ:LOGI – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at Wedbush in a research note issued to investors on Monday, RTT News reports. They presently... More of this article »
Image for IN8bio’s (INAB) “Buy” Rating Reiterated at HC Wainwright

IN8bio’s (INAB) “Buy” Rating Reiterated at HC Wainwright

IN8bio (NASDAQ:INAB – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research report issued to clients and investors on Friday, Benzinga reports. They currently... More of this article »